CD8+ T cell-based strong selective pressure on multiple simian immunodeficiency virus targets in macaques possessing a protective MHC class I haplotype
CD8+ T cell-based strong selective pressure on multiple simian immunodeficiency virus targets in macaques possessing a protective MHC class I haplotype
复制标题
基于 CD8 T 细胞的对具有保护性 MHC I 类单倍型的猕猴中多个猿猴免疫缺陷病毒靶标的强选择压力
DOI:
10.1016/j.bbrc.2019.03.003
复制
发表时间:
2019
影响因子:
3.1
通讯作者:
Yamamoto Hiroyuki
中科院分区:
文献类型:
--
作者:
Hau Trang Thi Thu;Nakamura-Hoshi Midori;Kanno Yoshiaki;Nomura Takushi;Nishizawa Masako;Seki Sayuri;Ishii Hiroshi;Kawana-Tachikawa Ai;Hall William W.;Nguyen Thi Lan Anh;Matano Tetsuro;Yamamoto Hiroyuki
In human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections, host major histocompatibility complex class I (MHC-I) genotypes have a great impact on viral replication and MHC-I-associated viral genome mutations are selected under CD8+T-cell pressure. Association of MHC-I genotypes with HIV/SIV control has been investigated at MHC-I allele levels but not fully at haplotype levels. We previously established groups of rhesus macaques sharing individual MHC-I haplotypes. In the present study, we compared viral genome diversification after SIV infection in macaques possessing a protective MHC-I haplotype,90-010-Id, with those possessing a non-protective MHC-I haplotype,90-010-Ie. These two MHC-I haplotypes are associated with immunodominant CD8+T-cell responses targeting similar regions of viral Nef antigen. Analyses of viral genome sequences and antigen-specific T-cell responses showed four and two candidates of viral CD8+T-cell targets associated with90-010-Idand90-010-Ie, respectively, in addition to the Nef targets. In these CD8+T-cell target regions, higher numbers of mutations were detected at the setpoint after SIV infection in macaques possessing90-010-Idthan those possessing90-010-Ie. These results indicate higher selective pressure on overall CD8+T-cell targets associated with the protective MHC-I haplotype, suggesting a pattern of HIV/SIV control by multiple target-specific CD8+T-cell responses.